Choo, J., Saini, J., Aguirre, A. G. -., Dahi, P., Hieronymi, S., Fernstedt, S., Tan, K. S., Adusumilli, P. S., Ku, G. Y. (2025). A phase I trial of intraperitoneal (IP) mesothelin (MSLN)-targeted CAR T-cell therapy in patients with MSLN-positive esophagogastric cancer (EGC) with peritoneal carcinomatosis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps513